Servomold is strengthening its focus on medical technology with a multi-million euro site expansion, adding state-of-the-art production and quality assurance facilities, including a high-precision 5-axis milling machine and advanced measuring systems.
Two generations with a feel for the future of toolmaking: from left to right: Lucas, Bianca and Thomas Meister, in front of the newly installed 5-axis precision milling machine in the fully air-conditioned production cell.
(Source: Joaquim Ferreira)
With a growing emphasis on the medical technology sector, Servomold has made a significant investment of nearly €5 million to expand its site. To this end, the company has invested almost 5 million euros in the local expansion of its site, which was only completed in 2018, to a total of 1,650 m2, 750 m2 of which is production space. The associated measures, which were implemented within 6 months, included the installation of a fully air-conditioned production cell and the acquisition of a high-precision 5-axis milling machine for the production of components with accuracies in the µm range. Servomold has expanded quality assurance by integrating a separately air-conditioned measuring room with state-of-the-art measuring and testing technology. The company currently employs 35 highly qualified employees in development, production and administration, 10 more than at the beginning of 2024.
The current order situation at Servomold confirms the course that has been set. At the turn of the year 2024/25, the share of the medical technology application area was already reaching 60 percent, with an upward trend. The remaining 40 percent is mainly divided between pharmaceutical, packaging and fluid technology and, to a lesser extent, automotive technology and miscellaneous industries. The space now available for production and quality assurance, as well as purchasing and warehousing, provides the perfect conditions for solving customer-specific tasks and manufacturing standard products.
Gallery
Managing Director Thomas Meister refers to the market success of the SLY servo-electric core pullers launched at Fakuma 2024 as the basis for this bold step. Thanks to their high production accuracy, they are able to position slides and cores in the injection mould with µm precision and significantly simplify the production effort for mould making. Their servo-electric drive and minimum quantity lubrication of the guides and spindles are specifically designed to be used in clean rooms. Both are fundamental requirements for manufacturers of sleeve-shaped components such as housings and cartridge holders for auto-injection systems. The full savings potential of these new units can be realised when the entire mould concept is designed accordingly — Servomold offers comprehensive conceptual support for this.
Ypsomed was one of the first manufacturers in the industry to recognise the potential of this concept and contributed its expertise to the project at an early stage. Meister comments: “The medical technology manufacturer produces injectors in quantities of several hundred million and uses a correspondingly large number of moulds for this. The agreement to work closely together beyond the development phase, and the prospect of equipping these moulds with our core pulling units, was the driving force behind our decision to expand and invest to this extent.” Thanks to these measures to increase vertical integration, Servomold is now able to manufacture its high-precision core pulling units entirely in-house. This enables the company to guarantee expected productivity and at the same time — system for system — the high precision as the overall responsible party. Meister continues: “By the end of 2025, we will be able to deliver more than 1,000 ready-to-install units per year.”
Over the past two years, Servomold has emphasised its expertise with a number of successful developments. In addition to the SLY core pulling units, these include the SLA servo linear actuators, which are also suitable for cleanrooms, and the compact servo screw actuators of the SSA series, which move slides, cores or plates in injection moulds powerfully and at high speed.
Meister: “With our products, we fulfil the high demands of our customers in medical technology and other demanding industries. State-of-the-art machinery and our excellently trained and highly motivated employees are the best prerequisites for continuing to play a leading role in the automation of injection moulds in the future.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.